New Year's Day and the Spring Festival holidays are approaching, but the rapid spread of the Aomi Kerong mutation strain in many countries around the world has aroused concern. Recently, local clusters of epidemics and sporadic cases have occurred in many parts of The country have made the situation of epidemic prevention and control very grim. Several places have even issued notices advocating the local New Year. To this end, the vast number of Chinese people are particularly concerned about whether they can go home during this year's Spring Festival. In response to this question, experts have given answers a few days ago.
According to domestic media reports on December 13, Zeng Guang, a well-known epidemiologist in China, recently answered the question of "whether you can go home for the New Year" that the general public is concerned about. Zeng Guang said, "I think the vast majority, should go home can go home." He pointed out that returning home during the Spring Festival is a general issue that needs to be considered comprehensively. Whether you can go home smoothly at that time depends on many factors, such as whether it is a green code and the risk level of the city. In addition, Zeng Guang believes that if there is no emergency, it is best to celebrate the New Year on the spot.
It should be mentioned that after the notice was issued in many places to advocate the local New Year, Hu Xijin, editor-in-chief of the Global Times, said in an article that he believes that the power to arrange how to celebrate the New Year should not only belong to the grass-roots governments in various places, but should be given national guidance by the National Health Commission, and the provinces should form policies according to local realities.
According to the news released by the official website of the National Health Commission of China, at 0-24:00 on December 12, 31 provinces (autonomous regions and municipalities directly under the Central Government) and the Xinjiang Production and Construction Corps reported 101 new confirmed cases. Among them, 21 cases were imported from abroad and 80 cases were indigenous cases. In response to the current epidemic situation, Wu Liangyou, deputy director of the Disease Control Bureau of the National Health Commission of China, pointed out that "external defense" has been prevented, so that there will be no internal rebound. New Year's Day and Spring Festival are approaching, and the risk of epidemic transmission is relatively large. We must make greater efforts in scientific and accurate epidemic prevention. Make sure you have a healthy, safe holiday season.
The new wave of outbreaks brought about by the Omikejung mutant strain has once again strained the world. As of December 9, the Omiljung strain had spread to 63 countries. The best way to deal with mutated viruses such as Opmi kerong at this stage is to vaccinate and strengthen them. At present, 1.15 billion people in China have completed full vaccination, accounting for 81.9% of the total population. But Zhong Nanshan, an academician of the Chinese Academy of Engineering, stressed that If China wants to achieve theoretical herd immunity, the vaccination rate should reach 83% of the total population.
Zhong Nanshan also pointed out that the vast majority of the current new crown vaccines, almost half a year after the market, the immune antibodies have declined, so it is necessary to play a booster. He stressed that the domestic vaccine booster injection is real and effective, and the prevention of the disease has increased from 50% to 80%. Experts are also stepping up research on how to make vaccinations more effective.
It is worth mentioning that at the time when the Omilon quickly spread to many countries in the world, good news came out from the Chinese side. On the 11th, China Kexing Company released the news that they have obtained nasopharyngeal swab samples of the infected person of the Semi kerong variant strain, and have successfully isolated the Omiljung mutant strain and obtained sequencing results. Kexing said that after obtaining the Aomi Kejong variant, the impact of the Aomi Kerong variant on the existing new crown vaccine can be better understood, and then the necessity of developing the Aomi Kerong variant vaccine can be evaluated. At the same time, Tengsheng Bo Medicine released news on the evening of the 12th that the first domestic new crown "special drug" maintained neutral activity on Aomi Kerong.